Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | LOC440248///HERC2P2///HERC2P3 |
Upstream (Parents) |
---|
(<<) LOC440345 → LOC440248///HERC2P2///HERC2P3 |
(<<) MYO9B → LOC440248///HERC2P2///HERC2P3 |
(<<) GAA → LOC440248///HERC2P2///HERC2P3 |
(<<) MCOLN1 → LOC440248///HERC2P2///HERC2P3 |
(<<) RFNG → LOC440248///HERC2P2///HERC2P3 |
Downstream (Children) |
---|
LOC440248///HERC2P2///HERC2P3 → HSD17B1 (>>) |
LOC440248///HERC2P2///HERC2P3 → KCNH6 (>>) |
LOC440248///HERC2P2///HERC2P3 → LOC145678 (>>) |
LOC440248///HERC2P2///HERC2P3 → PRKY (>>) |
LOC440248///HERC2P2///HERC2P3 → ZER1 (>>) |
LOC440248///HERC2P2///HERC2P3 → LOC440345 (>>) |
LOC440248///HERC2P2///HERC2P3 → KCNA4 (>>) |
LOC440248///HERC2P2///HERC2P3 → RPLP2 (>>) |
LOC440248///HERC2P2///HERC2P3 → SLC13A4 (>>) |
LOC440248///HERC2P2///HERC2P3 → MBD6 (>>) |
LOC440248///HERC2P2///HERC2P3 → CACNB4 (>>) |
LOC440248///HERC2P2///HERC2P3 → SLCO1C1 (>>) |